• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

DEVELOPMENT OF MATERIALS WHICH HAVE INHIBITORY ACTIVITY ON GRAFT-VERSUS-HOST DISEASE ACCOPANIED BY BONE MARROW TRANSPLANTATION

Research Project

Project/Area Number 05557032
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field 内科学一般
Research InstitutionTOKYO UNIVERSITY

Principal Investigator

ASANO Yoshihiro  UNIVERSIT OF TOKYO,FACULTY OF MEDICINE,DEPARTMENT OF IMMUNOLOGY,ASSOCIATE PROFESSOR, 医学部, 助教授 (70114353)

Co-Investigator(Kenkyū-buntansha) INOUE Tadahiro  SUMITOMO PHARMACEUTICAL CO.RESEARCH INSTITUTE RESEARCHER, 研究所, 研究員
Project Period (FY) 1993 – 1995
KeywordsGVHD / CELL DEATH / CLASS I / TH CELL CLONE / MONOCLONAL ANTIBODY
Research Abstract

The present study was carried out to develop a specific method to inhibit the graft versus host disease which may occur in organ transplantation and blood transfucion. For this purpose, we used a monoclonal antibody (RE2 antibody) which induces cell death specifically in activated lymphocytes but not resting lymphocytes nor somatic cells.
The features of the RE2 mAb are following : 1) RE2 directly killed IL2-dependent T cell clones, ConA- or LPS-activated spleen cells and lymph node cells, but not thymocyte, without participation of serum complement. Fab fragments of RE2 had no cytolytic activity, while the cross-linking of Fab fragments reconstituted the cytotoxicity. 2) Giant holes on the cell membrane were formed within 5 minutes after the treatment with RE2, as observed by scanning electron microscopy. There was no indication of DNA fragmentation nor swelling of mitochondria during the cytolysis, suggesting that the cell death is neither apoptosis nor typical necrosis. 3) Expression cloning study revealed that RE2 reacts with a family of MHC class I molecules including H-2K^K.
These results provide evidence for a novel pathway of cell death of activated lymphocytes by membrane excitation. It was also speculated that RE2 induces cell death through unknown molecule which associated with MHC class I molecules.

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Inoue,T.: "Distinction of mouse CD8^+suppressor effector T cell clones from cytotoxic T cell clones by cytdcine production and CD45 is forms." J.Immunol. 150. 2121-2128 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nagasawa, T.: "Negative selection of thymus-dependent CD4^+8^+ intraepihetial cymphocytes by internal superantigens." Cell. Immunol.147. 158-166 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kubo, S.: "A novel from of self tolerance in transgent wice with autoreactive T cell receptor α and β chaingenes." Int. Immunol.6. 593-602 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hoshi, S.: "Prevention of TCR-mediated αpoptosis by the elextion of CAMP." Int. Immunol.6. 1081-1089 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsuoka, S.: "A nevel type of cell deash of cymphocytes induced by a monoclonal antibody without paticipation of coupleneut" J. Exp. Med.181. 2007-2015 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kishimoto, H.: "Phygital dissociation of the TCR/CD3 Complex accompanies veceptor ligation." J. Exp. Med.182. 1997-2006 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yagita, H.: "Fas-medtated cytotoxicity-A new immunoregulatory and pathogene function of Th 1 CD4^+Tcells." Immunol, Rew.146. 223-239 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Dan, Y.: "IL3 upregulates TCR-mediated responses of type2 CD4 T cells." J. Immunol. 156. 27-34 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Inoue, T., Y.Asano, S.Matsuoka, M.Furutani-Seiki, S.Aizawa, H.Nishimura, T.Shirai, and T.Tada: "Distinction of mouse CD8^+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms." J.Immunol. 150. 2121-2128 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nagasawa, T., K.Sano, F.Ike, H.Kishimoto, T.Nakayama, Y.Asano, I.Ishikawa, and T.Tada: "Negative selection of thymus-dependent CD4^+8^+ intraepithelial lymphocytes by internal superantigens." Cell.Immunol. 147. 158-166 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kubo, S., T.Nakayama, M.Furutani-Seiki, H.Kishimoto, K.Hashimoto, M -J.Bae, T.Yokochi, N.Takeda, S.Aizawa, Y.Asano, and T.Tada: "A novel form of self tolerance in transgenic mice with autoreactive T cell receptor alpha and beta chein genes." Int.Immunol. 6. 593-602 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hoshi, S., Y.Asano, M.Furutani-Seiki, M.Seto, and T.Tada: "Prevention of TCR-mediated apoptosis by the elevation of cAMP." Int.Immunol. 6. 1081-1089 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsuoka, S., Y.Asano, K.Sano, H.Kishimoto, I.Yamashita, H.Yorifuji, M.Utsuyama, K.Hirokawa, and T.Tada: "A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement." J.Exp.Med. 181. 2007-2015 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Kishimoto, R.T.Kubo, H.Yorifuji, T.Nakayama, Y.Asano, and T.Tada: "Physical dissociation of the TCR/CD3 complex accompanies receptor ligation." J.Exp.Med. 182. 1997-2006 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yagita, H., S.Hanabuchi, Y.Asano, T.Tamura, H.Nariuchi, and K.Okumura: "Fas-mediated cytotoxicity-A new immunoregulatory and pathogenic function of Th1 CD4^+ T cells." Immunol.Rev. 146. 223-239 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Dan, Y., Y.Katakura, A.Ametani, S.Kaminogawa, and Y.Asano: "IL3 regulates TCR-mediated responses of type 2 CD4 T cells." J.Immunol. 156. 27-34 (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi